ARTICLE | Data Byte
Sharp increase in therapeutics deals from China to the West
Western companies struck 7x more deals to access Chinese tech last year than in 2013, and 2023 could see another increase
July 26, 2023 9:59 PM UTC
Political tensions between China and the West may be high, but the pace of biopharma deals between the regions shows no sign of slowing down, at least not yet.
As China’s life sciences industry has transformed itself from generics-heavy to innovation-focused, Western companies are increasingly doing deals to access therapeutic candidates and platform technologies from Chinese biotechs. ...